Home > Analytics > DR REDDYS LABORATORIES

DR REDDYS LABORATORIES
Intrinsic Value | Fundamental Analysis

BOM : 500124     NSE : DRREDDY    
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward
Pledged Shares : None or < 25%
Dec 03,2024
Price(EOD): ₹ 1,225.10
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 102,222.34 Cr
Value of ₹ 1 Lac invested in DR REDDYS LABORATORIES
on Dec 03,2019 (price: ₹ 571.81)

₹ 1 L

₹ 2.14 L

1W : 2.1% 1M : -3.9% 1Y : 6.9%
COMMUNITY POLL
for DR REDDYS LABORATORIES
Please provide your vote to see the results
DR REDDYS LABORATORIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Industry Peers & Returns1W1M1Y
DR REDDYS LABORATORIES 2.1% -3.9% 6.9%
SUN PHARMACEUTICAL INDUSTRIES 2.8% -2.7% 50.6%
CIPLA 2.9% -1.2% 25.5%
ZYDUS LIFESCIENCES 3.3% -2% 53.5%
DIVIS LABORATORIES 3.5% 5.4% 67.6%
MANKIND PHARMA 0.1% -4% 37.8%
TORRENT PHARMACEUTICALS 4.3% 5% 59.6%
LUPIN 3.7% -4.8% 65.6%
AUROBINDO PHARMA 3.5% -9.3% 22.9%

FUNDAMENTAL ANALYSIS OF DR REDDYS LABORATORIES

 
Fundamentals Score
[ Q(TTM): Sep2024, Y: Mar2024
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]

Insights 💡 DRREDDY is one of the top 35% companies with good fundamentals ! Discover More →

VALUATION OF DR REDDYS LABORATORIES

 
Valuation Score
[As on : Dec 03,2024 ]

Ratio Consolidated
P/E
P/B
P/S
18.91
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 5,406.80 Cr
[Latest Qtr - Sep2024 - Consolidated Results ]

3.63
P/B Calculated based on Book Value of Rs 28,123.50 Cr
[Latest Year - Mar2024 - Consolidated Results ]

3.4
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 30,084.90 Cr
[Latest Qtr - Sep2024 - Consolidated Results ]

Financial Ratios →

Insights 💡 There are potential 9% undervalued companies ! Discover More →

FAIR VALUE OF DR REDDYS LABORATORIES

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
4%
-1%
3%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF DR REDDYS LABORATORIES



DR REDDYS LABORATORIES vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF DR REDDYS LABORATORIES

Year Debt/Equity ratio
Standalone Consolidated
2024
2023
2022
Avg_3yrs
0.03
0
0.12
0.05
0.07
0.06
0.18
0.1
[Last Annual Data : Mar2024]
Financial Ratios →

PLEDGED PROMOTER SHARES OF DR REDDYS LABORATORIES

Pledged Promoter Shares
0 %
As on : Dec2023

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF DR REDDYS LABORATORIES

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
4.45%
-2.51%
1.84%
-3.66%
16.45%
3.4%
-0.06%
-9.62%
QtrlyTrend
0
Latest Qtr: Sep2024
Quarterly Result Analysis →


DR REDDYS LABORATORIES related INDICES

BSE Indices1W1M1Y
S&P BSE HEALTHCARE 2.8% 2.8% 49.4%
S&P BSE 500 2% 1.1% 29.2%
S&P BSE 250 LARGEMIDCAP 1.8% 1% 28.4%
S&P BSE LARGE MIDCAP 1.8% 0.9% 28%
S&P BSE 200 1.8% 0.9% 28.4%
NSE Indices1W1M1Y
NIFTY 100 EQUAL WEIGHT 2.8% NA 34.9%
NIFTY500 MULTICAP 50:25:25 2.4% 1.6% 32.1%
NIFTY HEALTHCARE 2.3% 0.9% 42.8%
NIFTY PHARMA 2.2% 0.3% 41.2%
NIFTY LARGE MIDCAP 250 2.2% 1.3% 31.4%

You may also like the below Video Courses


FAQ about DR REDDYS LABORATORIES


Is DR REDDYS LABORATORIES good for long term investment?

As on Dec 03,2024, the Fundamentals of DR REDDYS LABORATORIES look Strong and hence it may be good for long term investment! See Financial Performance of DR REDDYS LABORATORIES . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is DR REDDYS LABORATORIES UnderValued or OverValued?

As on Dec 03,2024, DR REDDYS LABORATORIES is Fairly Valued based on the estimates of intrinsic value and investors may wait for the buying opportunity once it becomes under valued!

What is the Intrinsic Value of DR REDDYS LABORATORIES ?

As on Dec 03,2024, the Intrinsic Value of DR REDDYS LABORATORIES is Rs. 1,195.05 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 1,178.80
Fair Value [Median EV / Sales Model] : Rs. 1,240.53
Fair Value [Median Price / Sales Model] : Rs. 1,195.05
Estimated Median Fair Value of DR REDDYS LABORATORIES : Rs. 1,195.05

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is DR REDDYS LABORATORIES trading at a Premium or Discount?

As on Dec 03,2024, DR REDDYS LABORATORIES is trading at a Premium of 3% based on the estimates of Median Intrinsic Value!